partnering

News

Owkin and MSD join forces on AI-powered digital pathology

Pharma group MSD has joined forces with Owkin to develop artificial intelligence-powered digital pathology diagnostics that could be used to identify patients suitable for

News

Daiichi Sankyo taps Depixus to speed RNA drug discovery

Daiichi Sankyo has made the development of RNA-based therapeutics and vaccines one of the pillars of its R&D operations and has turned to start-up Depixus to accelerat

News

BMS bolts on SystImmune bispecific ADC in $8.4bn deal

The litany of big-ticket deals involving antibody-drug conjugates shows no sign of ending.

News

Sanofi expands GenAI drug discovery pact with Aqemia

Sanofi has deepened an existing collaboration with artificial intelligence specialist Aqemia in the latest among a flurry of collaborations between pharma companies and ge

News

AstraZeneca links with Absci on AI for biologics discovery

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-

News

Boehringer puts IBM's GenAI into its antibody discovery tank

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibody discovery

Owkin and MSD join forces on AI-powered digital pathology

Daiichi Sankyo taps Depixus to speed RNA drug discovery

BMS bolts on SystImmune bispecific ADC in $8.4bn deal

Sanofi expands GenAI drug discovery pact with Aqemia

AstraZeneca links with Absci on AI for biologics discovery

Boehringer puts IBM's GenAI into its antibody discovery tank

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks